Study will collect real-world data on use of INOmax in COVID-19 patients
JADE REGIMEN study investigated JAK1 inhibitor in moderate to severe atopic dermatitis
Interim data analysis comes from phase III clinical trials in the Russian Federation
Company also announces new collaboration with Lacerta Therapeutics
New research examines 459 plant natural products that met rigorous criteria for demonstrating antibacterial activity.
With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site kblankenship Wed, 11/11/2020 […]
Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in […]
Forget glue, screws, heat or other traditional bonding methods. A Cornell University-led collaboration has developed a 3D printing […]
Almost one in five people in the US with covid-19 received a psychiatric diagnosis in the three months […]
Kar says that patients deserve honesty about the limits of the NHS.1 To quote Enoch Powell: “The worst […]